Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 12-Aug-14 5:11 PM View:  | Baupost Group Llc/ma 10% Owner | Idenix Pharmaceuticals Inc. (IDIX) | 05-Aug-14 | Disposition (other) | 53,331,100 | $24.50 | $1,306,610,048.00 | (100%) 53.33M to 0 | |
| 12-Aug-14 4:36 PM View: | Novartis Pharma Ag 10% Owner | Idenix Pharmaceuticals Inc. (IDIX) | 05-Aug-14 | Disposition (change in control) | 33,320,700 | $24.50 | $816,356,992.00 | (100%) 33.32M to 0 | |
| 11-Jul-14 4:09 PM View: | Renaud Ronald C Jr President & CEO Director | Idenix Pharmaceuticals Inc. (IDIX) | 19-Jun-14 | Acquisition (other) | 89,990 | -- | -- | 100% 0 to 89.99K | |
| 11-Jul-14 4:09 PM View: | Renaud Ronald C Jr President & CEO Director | Idenix Pharmaceuticals Inc. (IDIX) | 04-Jun-14 | Gift | 89,990 | -- | -- | (100%) 89.99K to 0 | |
| 04-Feb-14 4:25 PM View: | Baupost Group Llc/ma 10% Owner | Idenix Pharmaceuticals Inc. (IDIX) | 31-Jan-14 | Private Purchase | 16,420,200 | $6.50 | $106,732,000.00 | 44% 36.91M to 53.33M | |
| 17-Dec-12 6:05 PM View: | Renaud Ronald C Jr President & CEO Director | Idenix Pharmaceuticals Inc. (IDIX) | 14-Dec-12 | Option Exercise | 74,990 | $2.67 | $199,976.00 | 500% 15.0K to 89.99K | |
| 20-Mar-12 10:40 AM View: | Fanning Paul SVP, Human Resources | Idenix Pharmaceuticals Inc. (IDIX) | 16-Mar-12 | Option Exercise | 30,000 | $2.41 | $72,300.00 | 2308% 1.3K to 31.3K | |
| 20-Mar-12 10:40 AM View: | Fanning Paul SVP, Human Resources | Idenix Pharmaceuticals Inc. (IDIX) | 16-Mar-12 | Market Option Sale | 30,000 | $11.04 | $331,200.00 | (96%) 31.3K to 1.3K | 61% |
| 23-Feb-12 4:18 PM View: | Novartis Ag | Idenix Pharmaceuticals Inc. (IDIX) | 23-Feb-12 | Private Purchase | 84,893 | $3.43 | $291,283.00 | < 1% 33.24M to 33.32M | |
| 22-Nov-11 4:07 PM View: | Novartis Ag | Idenix Pharmaceuticals Inc. (IDIX) | 22-Nov-11 | Private Purchase | 50,530 | $4.08 | $206,400.00 | < 1% 33.19M to 33.24M | |
| 13-Apr-11 5:09 PM View: | Novartis Ag | Idenix Pharmaceuticals Inc. (IDIX) | 13-Apr-11 | Private Purchase | 1,785,710 | $2.80 | $5,000,000.00 | 6% 31.4M to 33.19M | (3%) |
| 25-Feb-11 10:48 AM View: | Novartis Ag | Idenix Pharmaceuticals Inc. (IDIX) | 25-Feb-11 | Private Purchase | 20,993 | $2.64 | $55,416.70 | < 1% 31.38M to 31.4M | |
| 26-Nov-10 7:49 AM View: | Novartis Ag | Idenix Pharmaceuticals Inc. (IDIX) | 26-Nov-10 | Private Purchase | 17,083 | $2.73 | $46,689.70 | < 1% 62.74M to 62.76M | |
| 23-Aug-10 2:49 PM View: | Novartis Ag | Idenix Pharmaceuticals Inc. (IDIX) | 23-Aug-10 | Private Purchase | 37,214 | $2.45 | $91,009.10 | < 1% 62.68M to 62.72M | |
| 08-Jun-10 1:47 PM View: | Novartis Ag | Idenix Pharmaceuticals Inc. (IDIX) | 08-Jun-10 | Private Purchase | 1,351 | $2.41 | $3,255.91 | < 1% 31.32M to 31.32M | |
| 26-Feb-10 11:28 AM View: | Novartis Ag | Idenix Pharmaceuticals Inc. (IDIX) | 26-Feb-10 | Private Purchase | 1,872 | $2.41 | $4,511.52 | < 1% 31.32M to 31.32M | |
| 17-Dec-09 10:13 AM View: | Hodgson Thomas R Director | Idenix Pharmaceuticals Inc. (IDIX) | 16-Dec-09 | Market Purchase | 10,387 | $2.12 | $22,020.40 | 13% 81.94K to 92.32K | 92% |
| 17-Dec-09 10:13 AM View: | Hodgson Thomas R Director | Idenix Pharmaceuticals Inc. (IDIX) | 15-Dec-09 | Market Purchase | 15,000 | $2.15 | $32,250.00 | 22% 66.94K to 81.94K | 90% |
| 14-Dec-09 5:29 PM View: | Hodgson Thomas R Director | Idenix Pharmaceuticals Inc. (IDIX) | 14-Dec-09 | Market Purchase | 11,000 | $2.12 | $23,320.00 | 20% 55.94K to 66.94K | 92% |
| 14-Dec-09 5:29 PM View: | Hodgson Thomas R Director | Idenix Pharmaceuticals Inc. (IDIX) | 11-Dec-09 | Market Purchase | 8,613 | $2.08 | $17,915.00 | 18% 47.32K to 55.94K | 96% |
| 14-Dec-09 5:29 PM View: | Hodgson Thomas R Director | Idenix Pharmaceuticals Inc. (IDIX) | 10-Dec-09 | Market Purchase | 5,000 | $2.05 | $10,250.00 | 12% 42.32K to 47.32K | 99% |
| 24-Nov-09 4:42 PM View: | Weidenbruch John Ex. VP, Gen. Counsel and Secr. | Idenix Pharmaceuticals Inc. (IDIX) | 24-Nov-09 | Market Purchase | 20,000 | $1.89 | $37,800.00 | 133% 15.0K to 35.0K | 116% |
| 13-Nov-09 2:09 PM View: | Standring David EVP, Biology | Idenix Pharmaceuticals Inc. (IDIX) | 11-Nov-09 | Option Exercise | 15,000 | $1.00 | $15,000.00 | 29% 52.58K to 67.58K | |
| 24-Aug-09 4:40 PM View: | Novartis Ag | Idenix Pharmaceuticals Inc. (IDIX) | 21-Aug-09 | Private Purchase | 3,431 | $2.41 | $8,268.71 | < 1% 31.32M to 31.32M | |
| 29-May-09 3:49 PM View: | Novartis Ag | Idenix Pharmaceuticals Inc. (IDIX) | 29-May-09 | Private Purchase | 2,451 | $2.62 | $6,421.62 | < 1% 31.31M to 31.32M | |
| 23-Feb-09 2:51 PM View: | Novartis Ag | Idenix Pharmaceuticals Inc. (IDIX) | 23-Feb-09 | Private Purchase | 5,444 | $2.41 | $13,120.00 | < 1% 31.31M to 31.31M | 97% |
| 25-Nov-08 5:27 PM View: | Novartis Ag | Idenix Pharmaceuticals Inc. (IDIX) | 19-Nov-08 | Private Purchase | 4,747 | $4.05 | $19,225.40 | < 1% 31.3M to 31.31M | 55% |
| 17-Sep-08 4:08 PM View: | Sommadossi Jean-Pierre President, CEO, Chairman Director | Idenix Pharmaceuticals Inc. (IDIX) | 16-Sep-08 | Disposition (other) | 110,000 | $8.00 | $880,000.00 | (5%) 2.33M to 2.22M | 54% |
| 03-Sep-08 12:42 PM View: | Novartis Ag 10% Owner | Idenix Pharmaceuticals Inc. (IDIX) | 02-Sep-08 | Private Purchase | 4,654 | $2.93 | $13,636.20 | < 1% 31.3M to 31.3M | 190% |
| 30-May-08 3:15 PM View: | Novartis Ag 10% Owner | Idenix Pharmaceuticals Inc. (IDIX) | 29-May-08 | Private Purchase | 924 | $2.41 | $2,226.84 | < 1% 31.3M to 31.3M | 149% |
| 13-Mar-08 8:08 AM View: | Mayers Douglas L EVP and Chief Medical Officer | Idenix Pharmaceuticals Inc. (IDIX) | 11-Mar-08 | Market Purchase | 30,000 | $4.45 | $133,500.00 | 100% 0 to 30.0K | (18%) |
| 13-Mar-08 8:10 AM View: | Weidenbruch John Ex. VP, Gen. Counsel and Secr. | Idenix Pharmaceuticals Inc. (IDIX) | 11-Mar-08 | Private Purchase | 15,000 | -- | -- | 100% 0 to 15.0K | |
| 11-Mar-08 10:42 AM View: | Renaud Ronald C Jr Chief Financial Officer | Idenix Pharmaceuticals Inc. (IDIX) | 11-Mar-08 | Private Purchase | 15,000 | -- | -- | 100% 0 to 15.0K | |
| 19-Jul-07 2:55 PM View: | Koppy Susan Sr. VP, Business and Corp Dev. | Idenix Pharmaceuticals Inc. (IDIX) | 13-Jul-07 | Market Purchase | 400 | $3.84 | $1,536.00 | 160% 0.25K to 0.65K | (5%) |
| 08-Jun-06 3:08 PM View: | Novartis Ag 10% Owner | Idenix Pharmaceuticals Inc. (IDIX) | 06-Jun-06 | Purchase | 365 | $20.48 | $7,475.20 | < 1% 31.3M to 31.3M | |
| 11-May-06 4:36 PM View: | Sommadossi Jean-Pierre President, CEO, Chairman Director | Idenix Pharmaceuticals Inc. (IDIX) | 09-May-06 | Market Purchase | 10,000 | $9.13 | $91,300.00 | < 1% 2.2M to 2.21M | (60%) |
| 10-May-06 5:17 PM View: | Koppy Susan Sr. VP, Business and Corp Dev. | Idenix Pharmaceuticals Inc. (IDIX) | 08-May-06 | Market Purchase | 200 | $9.26 | $1,852.00 | 400% 50 to 0.25K | (61%) |
| 06-Apr-06 3:35 PM View: | Novartis Ag 10% Owner | Idenix Pharmaceuticals Inc. (IDIX) | 04-Apr-06 | Purchase | 2,938 | $16.23 | $47,683.70 | < 1% 31.3M to 31.3M | |
| 16-Nov-05 2:56 PM View: | Pollard-Knight Denise Director | Idenix Pharmaceuticals Inc. (IDIX) | 14-Nov-05 | Market Sale | 629,498 | $20.61 | $12,974,000.00 | (68%) 930.97K to 301.48K | 82% |
| 02-Nov-05 3:50 PM View: | Novartis Ag 10% Owner | Idenix Pharmaceuticals Inc. (IDIX) | 31-Oct-05 | Market Purchase | 3,939,130 | $20.61 | $81,185,504.00 | 14% 27.36M to 31.3M | (82%) |
| 07-Sep-05 2:52 PM View: | Novartis Ag 10% Owner | Idenix Pharmaceuticals Inc. (IDIX) | 02-Sep-05 | Grant | 1,187,090 | $20.18 | $23,955,500.00 | 5% 26.17M to 27.36M | (82%) |
| 10-Feb-06 10:00 PM View: | Sommadossi Jean-Pierre President, CEO, Chairman Director | Idenix Pharmaceuticals Inc. (IDIX) | 06-Apr-05 | Gift | 159,345 | -- | -- | (7%) 2.36M to 2.2M | |
| 30-Aug-04 4:57 PM View: | Sommadossi Jean-Pierre President, CEO, Chairman Director | Idenix Pharmaceuticals Inc. (IDIX) | 26-Aug-04 | Option Exercise | 43,750 | $8.50 | $371,875.00 | 2% 2.32M to 2.36M | |
| 28-Jul-04 12:07 PM View: | Novartis Ag 10% Owner | Idenix Pharmaceuticals Inc. (IDIX) | 27-Jul-04 | Market Purchase | 6,500,000 | $11.63 | $75,600,000.00 | 31% 20.86M to 27.36M | (69%) |
| 28-Jul-04 4:27 PM View: | Gadicke Ansbert Director 10% Owner | Idenix Pharmaceuticals Inc. (IDIX) | 27-Jul-04 | Private Sale | 508,371 | $14.00 | $7,117,190.00 | (10%) 5.31M to 4.8M | |
| 29-Jul-04 3:23 PM View: | Sommadossi Jean-Pierre President, CEO, Chairman Director | Idenix Pharmaceuticals Inc. (IDIX) | 27-Jul-04 | Purchase | 6,364 | $14.00 | $89,096.00 | < 1% 2.31M to 2.32M | |
| 29-Jul-04 1:45 PM View: | Egan James Sr. VP, Business and Corp Dev | Idenix Pharmaceuticals Inc. (IDIX) | 27-Jul-04 | Purchase | 13,400 | $14.00 | $187,600.00 | 6% 215.88K to 229.28K | |
| 29-Jul-04 12:49 PM View: | Pollard-Knight Denise Director | Idenix Pharmaceuticals Inc. (IDIX) | 27-Jul-04 | Disposition | 100,278 | $14.00 | $1,403,890.00 | (10%) 1.03M to 930.97K | |
| 28-Jul-04 4:29 PM View: | Bb Bioventures L P 10% Owner | Idenix Pharmaceuticals Inc. (IDIX) | 27-Jul-04 | Private Sale Duplicate | 508,371 | $14.00 | $7,117,190.00 | (10%) 5.31M to 4.8M | |
| 29-Jul-04 12:42 PM View: | Barshefsky Charlene Director | Idenix Pharmaceuticals Inc. (IDIX) | 27-Jul-04 | Purchase | 20,000 | $14.00 | $280,000.00 | 48% 41.34K to 61.34K |
